Rs 23 lakh crore boom! PMS and AIFs power India’s alternate investment transformation
India’s alternatives investment ecosystem has entered a new phase of scale, with Portfolio Management Services (PMS) and Alternative Investment Funds ...
Tag: crore
Block deals today: Goldman Sachs, BofA sell Rs 119 crore worth shares in RIL, HDFC Bank and Apollo Hospitals
D-Street witnessed a bunch of block deals involving top names such as Reliance Industries (RIL), HDFC Bank and Apollo Hospitals ...
Rs 9,400 crore stake! Groww’s dominance on Dalal Street turns founder Lalit Keshre into a billionaire
As Groww continues to assert its dominance on Dalal Street with a stunning 68% surge in its share price since ...
Foreign investors sell Indian stocks worth Rs 13,925 crore in November. Here’s what analysts say
Foreign institutional investors (FIIs) have offloaded Rs 13,925 crore worth of Indian equities between November 1 and November 14, marking ...
Max Health Q2 Results: Nifty’s latest entrant reports 74% YoY jump in cons PAT to Rs 491 crore, revenue grows 25%
Nifty's latest addition, Max Healthcare Institute, on Friday reported a 74% year-on-year growth in its September quarter consolidated net profit ...
Dish TV Q2 net loss widens to Rs 133 crore
Dish TV India reported a net loss of Rs 133 crore for the quarter ended September 30, 2025, widening from ...
Tata Steel shares in focus after Q2 PAT surges fourfold to Rs 3,183 crore
Tata Steel shares are expected to be in the spotlight on Thursday, November 13, after the company reported a substantial ...
NDR InvIT Trust reports 36% YoY PAT growth, revenue hits Rs 1036 crore in Q2 FY26
NDR InvIT Trust, India’s pioneering Perpetual Warehousing and Industrial Parks InvIT, announced robust financial results for the quarter ended September ...
BSE shares in focus as Q2 PAT surges 61% YoY to Rs 558 crore
BSE shares are likely to attract investor attention on Wednesday, November 12, after reporting a strong 61% year-on-year (YoY) growth ...
Biocon Q2 Results: Profit soars 428% YoY to Rs 85 crore on strong biosimilar and generics growth
Biocon Group on Tuesday reported a 20% year-on-year increase in operating revenue in the second quarter of FY26 to Rs ...
Recent News
